|
|
 |
|
Viewing report
|
|
|
|
Injectable Drug Delivery: Market Impact and Industry Trends
Arrowhead Publishers, Oct 2006
As competition in the pharmaceutical marketplace grows, companies are increasingly looking towards the drug delivery industry to maximize revenues and combat generic competitors. The search for more efficient drug delivery systems is also being driven by the rise in patient demand, healthcare and pharma cost containment, as much as by medical and technological advances.
The global market for drug delivery technology is worth in excess of US$25 billion in sales. Given its predicted annual growth of 15 percent, the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists. According to our new report entitled Injectable Drug Delivery: Market Impact and Industry Trends, injectables currently account for an estimated 15 percent of the global drug delivery market, with the US being the leading individual market.
Key features of this report:
- Overview of the drug delivery environment
- In-depth analysis of the injectable drug delivery industry, including main types and main marketed
systems, and their advantages and disadvantages
- Comprehensive facts and figures for the injectable drug delivery market, including main players and key
therapeutic areas
- Future trends in the injectables marketplace, shaped by medical and technological advances as much as
demographic and epidemiological changes and industry needs
- Outlook for the injectable drug delivery technology
Who should buy this report?
- Stakeholders in the injectable drug delivery market
- Companies interested in understanding the impact and implications of securing the correct injectable drug
delivery technology in terms of product placement, lifecycle management and competition in the
marketplace
- Companies interested in understanding future opportunities in the injectable drug delivery sector provided
by a combination of factors, including changing public health needs
- Pharma/biotech companies wishing to identify potential injectable drug delivery areas for partnerships
and collaboration in order to examine a variety of profit maximization strategies
Products Mentioned
- Cimzia (Nektar)
- Mircera/CERA (Nektar)
- Paliperidone Palmitate (Johnson & Johnson)
- Intraject Sumatriptan (Zogenix)
- Neulasta (Nektar/Amgen)
- PEGASYS (Roche/Nektar)
- PEG-Intron (Schering-Plough)
- Risperdal Consta
- Sandostatin (Novartis)
- Vivitrol (Alkermes)
Customers who bought this item also bought
Injectable Drug Delivery
Injectable Drug Delivery: Probing the Route to Growth
Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
U.S. Injectable Drug Pipeline
Drug Delivery in Cancer - Technologies, Markets and Companies
Drug Delivery Technology - Revolutionizing Cancer Therapies
Effective Deal Making in Drug Delivery
Nanoparticle Drug Delivery Market Report
Transdermal Drug Delivery - Technologies, Markets, and Companies
The Global Drug Delivery Market - Research Trends and Market Outlook
The Top 40 Transdermal Drug Delivery Technology Companies Worldwide
Injectable Generic Drugs: Prospects & Opportunities to 2013
|
|
|
|
